AU7294196A - Stable pharmaceutical forms of administration containing parathormone - Google Patents

Stable pharmaceutical forms of administration containing parathormone

Info

Publication number
AU7294196A
AU7294196A AU72941/96A AU7294196A AU7294196A AU 7294196 A AU7294196 A AU 7294196A AU 72941/96 A AU72941/96 A AU 72941/96A AU 7294196 A AU7294196 A AU 7294196A AU 7294196 A AU7294196 A AU 7294196A
Authority
AU
Australia
Prior art keywords
parathormone
pharmaceutical forms
stable pharmaceutical
administration containing
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72941/96A
Inventor
Rolf-Dieter Gabel
Wolfgang Rodel
Hendrik Von Bueren
Heinrich Woog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU7294196A publication Critical patent/AU7294196A/en
Assigned to ROCHE DIAGNOSTICS GMBH reassignment ROCHE DIAGNOSTICS GMBH Amend patent request/document other than specification (104) Assignors: BOEHRINGER MANNHEIM GMBH
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU72941/96A 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone Abandoned AU7294196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19538687A DE19538687A1 (en) 1995-10-17 1995-10-17 Stable pharmaceutical dosage forms containing parathyroid hormone
DE19538687 1995-10-17
PCT/EP1996/004503 WO1997014429A1 (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Publications (1)

Publication Number Publication Date
AU7294196A true AU7294196A (en) 1997-05-07

Family

ID=7775105

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72941/96A Abandoned AU7294196A (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Country Status (14)

Country Link
EP (1) EP0855917A1 (en)
JP (1) JPH11515002A (en)
KR (1) KR19990064322A (en)
AU (1) AU7294196A (en)
BR (1) BR9610983A (en)
CA (1) CA2234724A1 (en)
CZ (1) CZ108398A3 (en)
DE (1) DE19538687A1 (en)
HU (1) HUP9900751A3 (en)
NZ (1) NZ320237A (en)
SK (1) SK47298A3 (en)
TR (1) TR199800690T1 (en)
WO (1) WO1997014429A1 (en)
ZA (1) ZA968715B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (en) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Preparations and processes for stabilizing biological materials by means of drying processes without freezing
DE19716154A1 (en) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stable pharmaceutical dosage form for peptides, proteins and nucleic acids
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
SE9801495D0 (en) * 1998-04-28 1998-04-28 Astra Ab Protein formulation
WO2001032201A2 (en) * 1999-10-29 2001-05-10 Eli Lilly And Company A pharmaceutical composition having high cell membrane permeability
PT1253932E (en) * 2000-02-08 2005-07-29 Allergan Inc PHARMACEUTICAL COMPOUNDS OF BOTULINIC TOXIN
US7087248B2 (en) 2000-06-30 2006-08-08 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
JP4607010B2 (en) * 2003-02-28 2011-01-05 中外製薬株式会社 Protein-containing stabilized preparation
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
KR100700869B1 (en) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 The stabilized parathyroid hormone composition comprising parathyroid hormone buffer and stabilizing agent
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2947181B1 (en) * 2009-06-26 2012-05-04 Lfb Biotechnologies FACTOR VII COMPOSITION
CN108195965B (en) 2011-06-07 2021-02-23 旭化成制药株式会社 Method for testing PTH peptide-containing lyophilized preparation, and method for producing pharmaceutical product containing PTH peptide-containing lyophilized preparation
IL297369B1 (en) 2015-04-29 2024-02-01 Radius Pharmaceuticals Inc Rad1901 for use in a method of treatmenet of mutant estrogen receptor positive breast cancer or a mutanat estrogen receptor positive ovarian cancer
JP6634758B2 (en) * 2015-09-25 2020-01-22 ニプロ株式会社 Liquid composition and freeze-dried preparation
KR102322802B1 (en) 2017-01-05 2021-11-04 래디어스 파마슈티컬스, 인코포레이티드 Polymorphic form of RAD1901-2HCL
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP6577683B2 (en) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 Liquid pharmaceutical composition containing teriparatide having excellent stability
US11643385B2 (en) 2018-07-04 2023-05-09 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl
WO2021229835A1 (en) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 Stable liquid pharmaceutical preparation containing teriparatide or salt thereof
JP6947946B1 (en) * 2020-05-11 2021-10-13 旭化成ファーマ株式会社 Stable liquid pharmaceutical product containing teriparatide or a salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
JP2739482B2 (en) * 1988-08-11 1998-04-15 バイオ・チバ株式会社 Method for producing stable calcitonin injection
JPH0341033A (en) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd Stable preparation containing motilins
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
DE4203040A1 (en) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh NEW PARATHORMON FRAGMENTS, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM

Also Published As

Publication number Publication date
CZ108398A3 (en) 1998-09-16
TR199800690T1 (en) 1998-06-22
WO1997014429A1 (en) 1997-04-24
SK47298A3 (en) 1998-11-04
BR9610983A (en) 1999-03-02
HUP9900751A3 (en) 2000-07-28
DE19538687A1 (en) 1997-04-24
KR19990064322A (en) 1999-07-26
HUP9900751A2 (en) 1999-07-28
EP0855917A1 (en) 1998-08-05
NZ320237A (en) 1999-11-29
ZA968715B (en) 1998-04-16
CA2234724A1 (en) 1997-04-24
JPH11515002A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU6995396A (en) Pharmaceutical formulation
AU5945296A (en) Medicament for nasal administration
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
AU7572196A (en) Pharmaceutical formulations
AU6534894A (en) Drug administration system
AU7499096A (en) Stable freeze-dried pharmaceutical formulation
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7742194A (en) Potentiation of drug response
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU6973396A (en) Pharmaceutical formulation
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
AU5710896A (en) Intrapulmonary delivery of hematopoietic drug
AU1847695A (en) Pharmaceutical formulations of cntf
AU7582696A (en) Pharmaceutical formulation
AU1766592A (en) Pharmaceutical formulations of a benzodiazepine
AU4843996A (en) Imidazole derivatives and medicinal composition thereof
AU3690495A (en) Pharmaceutical composition containing derivatives of sex hormones
GB9601186D0 (en) Administration of Drugs
IL116910A0 (en) Novel pharmaceutical formulation for topical administration
AU7305496A (en) Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
IL106108A0 (en) Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted